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Introduction
Severe sepsis induces a state of immunoparalysis.[1]
Animal models have demonstrated this to be secondary to
microbial-induced host epigenetic alterations, which per-
sist and are associated with long-term immunoparalysis.[2]
Whilst human sepsis is associated with poor long-term
outcomes in conjunction with recurrent infections,[3] it is
not clear if the immunoparalysed state persists following
recovery from the initial septic insult.
Objectives
1. To confirm the presence of circulating mediators cap-
able of causing immunoparalysis following bacteraemia.
2. To assess for the presence of immunosuppressive
mediators following hospital discharge with full functional
recovery.
Methods
Consecutive adult patients (n = 7) with bacteraemia and
an admission diagnosis of infection were recruited. Serum
was collected at 3 time points; within 48 hours of the
positive blood culture, 5 days later & 12 months following
hospital discharge. Peripheral blood mononuclear cells
(PBMCs) were collected from a healthy control cohort
(n = 7) and pooled. Healthy PBMCs were co-cultured with
30% septic serum for 20 hours with and without GM-CSF
(200ng/ml). CD14+HLA-DR (mHLA-DR) geometric-mean
fluorescent intensity (MFI) was determined using flow
cytometry. Data were analysed with non-parametric statis-
tics with results presented as median & IQR .
Results
Three patients required ICU care & four were managed on
the ward. Demographic & clinical data are presented in
Figure 2. mHLA-DR levels were lower when PBMCs were
co-cultured with the baseline bacteraemic sample in com-
parison with control group serum (Figure 1, P = 0.01).
mHLA-DR levels following co-culture with the baseline
sample were not significantly different to the levels
observed when co-cultured with day 5 serum (Figure 1A).
In comparison to the baseline sample, when co-cultured
with serum from 12 months, mHLA-DR levels were
increased (Figure 1A, P = 0.007). mHLA-DR levels at 12
months were not different from those seen when control
serum was used (Figure 1AP = 0.85). mHLA-DR levels
were higher in the presence of GM-CSF when co-cultured
with baseline (Figure 1B, P = 0.01) and 12 month
(Figure 1B, P = 0.02) samples but not with day 5 serum
(Figure 1B, P = 0.17).
Conclusions
Circulating mediators present in the serum of bacteraemic
patients reduces the ability of healthy monocytes to
express cell surface HLA-DR, which is reversible in the
presence of an immunostimulant. Serum from patients
following full recovery from the acute illness does not
reduce HLA-DR expression on healthy monocytes.
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Figure 2 Demographic and clinical details of patients requiring
ICU care (severe sepsis) and those receiving ward based care
(no organ impairment).
Figure 1
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